Abiopharma

Became an interested party - Neta Shuster

Management and officers – staffing as of 20.8.26

Q2 2026 Investors Presentation

The company’s outstanding liabilities as of June 30, 2026, by maturity dates

Q2/semi-annual report for 2026

Repayment of the Apollo loan and completion of Preferred Equity investments in the Indiana Center 1 and 2 projects

Conference call to review the financial statements as of 30.6.26 on 20.8.26 at 12:00

Invitation to a special meeting for 24.8.26 – supplementary proxy statement following discussions with the advisors of institutional bodies

Ceased to be an interested party - Mor Multi Strategies - Limited Partnership

Register of shareholders, changes and share capital status – non-material and non-unusual private allocation of the company’s shares and expiration of employee warrants not listed for trading